3Wright A, Burden AC, Paisey RB, et al. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U. K. Prospective Diabetes Study (UKPDS 57)[J]. Diabetes Care,2002,25(2):330-336. 被引量：1
4American Diabetes Association. Standards of medical care in diabetes-2011[J]. Diabetes Care, 2011,34 (Suppl 1): S11-61. 被引量：1
5Hamaty M. Insulin treatment for type 2 diabetes:when to start, which to use[J]. Cleve Clin J Med,2011,78(5) :332-342. 被引量：1
3[1]Ezzati M,Lope AD,Rodgers A,et al.Elected major risk factors and global and regional burden of disease[J].Lancet,2002,360(9343):1347-1460. 被引量：1
4[2]Perriere G,Thioulouse J.Use and misuse of correspondence analysis in codon usage studies[J].Nucleic Acids Research,2002,30(20):4548-4555. 被引量：1
5[3]Busold CH,Winter S,Hauser N,et al.Integration of go annotations in Correspondence Analysis:facilitating the interpretation of micro-array data[J].Bioinformatics,2005,21(10):2424-2429. 被引量：1
